(lp0
S'Meridian Bioscience Inc.  Moves Higher on Volume Spike for March 17 Equities.com - 18 hours ago Meridian Bioscience Inc.  traded on unusually high volume on Mar. 17, as the stock gained 1.49% to close at $13.60. On the day, Meridian Bioscience Inc. saw 636,549 shares trade hands on 1,848 trades. Considering that the stock averages only a&nbsp;...New York State Teachers Retirement System Sells 200 Shares of Meridian ... - BNB Daily '
p1
aS'Magellan Diagnostics  Continues ... GlobeNewswire  - Mar 7, 2017 CINCINNATI, March 07, 2017  -- Meridian Bioscience, Inc.  announced today that Magellan Diagnostics Inc., a business unit of Meridian since March 2016, has signed an exclusive distribution agreement with Biofirm&nbsp;...'
p2
aS'BRIEF-Meridian Bioscience Inc signs an exclusive distribution agreement with ... Reuters - Mar 7, 2017 BRIEF-Meridian Bioscience Inc signs an exclusive distribution agreement with Biofirm Technologies. March 7 Meridian Bioscience Inc: * Meridian Bioscience Inc- Magellan Diagnostics , a business unit signed an exclusive distribution agreement with ...'
p3
aS"Here's Why Meridian Bioscience, Inc. Stock Is Having a Rough Day Motley Fool - Jan 25, 2017 Shares of Meridian Bioscience, Inc. , a diagnostics-focused life-science company, fell hard at the open Wednesday, and were still off about 19.8% at 12:01 p.m.Meridian Bioscience stock drops 9% on first-quarter earnings and revenue ... - MarketWatch"
p4
aS'Pawar Law Group Announces Investigation of Securities Claims Against Meridian ... Yahoo Finance - Feb 7, 2017 NEW YORK, NY / ACCESSWIRE / February 7, 2017 / The Pawar Law Group announces it is investigating potential securities claims on behalf of shareholders of Meridian Bioscience, Inc.   resulting from allegations that management&nbsp;...'
p5
aS'Common Share Dividend Yield of Meridian Bioscience Inc.  Energy Index - Mar 15, 2017 The dividend growth rate of Meridian Bioscience  calculated based on 20 historical quarterly dividends is 1.49% while the R-Squared dividend growth rate regression is 0.72.'
p6
aS'Meridian Bioscience, Inc.  Valuation Review &amp; Update Business Review - Mar 16, 2017 The ERP5 Rank is an investment tool that analysts use to discover undervalued companies. The ERP5 looks at the Price to Book ratio, Earnings Yield, ROIC and 5 year average ROIC.'
p7
aS'Meridian Bioscience, Inc. Receives FDA Clearance for New Molecular Test for ... GlobeNewswire  - Jun 15, 2016 CINCINNATI, June 15, 2016  -- Meridian Bioscience, Inc.  today announced that it has received FDA clearance for a new molecular diagnostic test for Mycoplasma pneumonia (M.'
p8
aS'Meridian Bioscience Reports Fourth Quarter and Full-Year Operating Results ... GlobeNewswire  - Nov 10, 2016 reported fourth quarter fiscal 2016 net earnings of $5.5 million, or $0.13 per diluted share, on a GAAP basis, a 35% decrease compared to the fiscal 2015 fourth quarter.'
p9
aS"Option Market: Meridian Bioscience Inc Risk Hits An Inflection Point CML News - Mar 16, 2017 We're going to look at a proprietary risk rating for the next 30-days built by Capital Market Laboratories  based on a large number of interactions of data points, many of which come directly from the option market for Meridian Bioscience Inc&nbsp;..."
p10
a.